Streetbeat News

Revenues

PBI

Pitney Bowes has increased the savings target of its cost rationalization program from $60 million-$100 million to $120 million-$160 million.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:17 pm

GES

Guess? Inc. has expanded its existing European credit facility by €100 million, which will provide the company with additional financial flexibility to support its operations and growth initiatives in Europe.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:16 pm

NRXP

NRx Pharmaceuticals has provided a shareholder update outlining potential revenue and profitability paths for 2025. The company anticipates revenue in 2024 from HOPE Therapeutics-branded clinics and in 2025 from the sales of NRX-100 (IV Ketamine) pending FDA approval, as well as NRX-101 for suicidal bipolar depression and akathisia.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:15 pm

BAH

Booz Allen Hamilton (NYSE: BAH) has been awarded a $419 million, seven-year contract by the National Science Foundation to modernize and support its IT operations. This contract will enhance the NSF's merit review and grants management system, leveraging Booz Allen's expertise in IT transformation.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:09 pm

SNTI

Senti Bio shares are trading higher after the company was awarded $8 million from the California Institute for Regenerative Medicines to support the development of SENTI-202.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:07 pm

SNTI

Senti Bio has been awarded an $8 million grant from the California Institute for Regenerative Medicines to support the ongoing development of SENTI-202.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:07 pm

SGML

Sigma Lithium Corporation (NASDAQ:SGML) has completed the sale of its 10th shipment of 22,000t of Quintuple Zero Green Lithium at a premium price of 8.75% of LME Lithium Hydroxide. This shipment will be sent in early July, marking 11 months of consistent operations.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:05 pm

LI

NIO

TSLA

XPEV

Tesla's stock is set to breach the $200 mark in premarket trading, driven by optimism around its upcoming Q2 deliveries report and a rebound in China sales. Positive sentiment is also fueled by strong June sales from domestic EV startups Nio, XPeng, and Li Auto.

Portfolio Pulse from Shanthi Rexaline

July 01, 2024 | 12:03 pm

BIOR

Biora Therapeutics announced positive clinical trial results for BT-600, a drug-device combination using the NaviCap™ platform to deliver tofacitinib directly to colonic tissue for ulcerative colitis treatment. The trial met all objectives, showing effective drug absorption in the colon. A virtual event with key opinion leaders is scheduled for July 17.

Portfolio Pulse from Benzinga Newsdesk

July 01, 2024 | 12:01 pm

TMUS

T-Mobile US (NASDAQ:TMUS) has been analyzed by 7 analysts in the last quarter, with ratings ranging from bullish to somewhat bullish. The average 12-month price target has increased to $194.29 from $188.00. Key analysts from firms like Goldman Sachs, B of A Securities, and Benchmark have maintained or raised their ratings and price targets. Despite a slight revenue decline, T-Mobile US shows strong financial health with high net margins, ROE, and ROA, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

July 01, 2024 | 12:01 pm